An increase in the number of hospital-acquired infections, especially in the developing and underdeveloped economies has surged the demand in the hospital-acquired control market. Different emerging economies such as India, China, South Africa, Brazil, and Mexico are witnessing a surge in the number of under-served patients.
Economic development in these regions is creating scopes of the growth for the manufacturers on the back of a large patient pool. Growth in medical expenditure and infrastructure encouraged by the governments of the respective economies is enhancing the adoption rate of sophisticated medical devices, generating substantial revenue in the market. High demand for devices such as endoscope reprocessing devices which are capable of disinfecting medical devices is pushing ahead the boundaries of growth of the market. Innovations focused on avoiding cross contaminations and enhancing the patients' safety are gaining preference in the medical sector.
Major market players are investing in the growing markets such as the US and UK. The companies are leveraging innovative technologies to revolutionize the cleaning process.
Market players are taking advantage of the enhanced healthcare expenditure to expand their market. Prominent players in the market are Pfizer Inc., Olympus Corporation, Abbott Laboratories, The 3M Company, F. Hoffmann-La Roche Ltd, Advanced Sterilization Products Services Inc. (Johnson & Johnson), and Merck & Co., Inc.
The global hospital acquired infections control market is expected to witness robust growth during the forecast period. The number of hospital acquired infections has triggered the need for a separate sterile unit in hospitals where the equipment is sterilized and reprocessed. There are surprise checks by the regulatory authorities to ensure the utilization of sterilized equipment and consumables.
Find Out More about the Report Coverage
- Olympus Corporation
- Medivators Inc. (Cantel Medical Corp.)
- Getinge Group
- STERIS Plc.
- Belimed AG (Metall Zug)
- Steelco S.P.A
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Advanced Sterilization Products Services Inc. (Johnson & Johnson)
- Abbott Laboratories
- Bayer AG
- Alere Inc.
- The 3M Company
- Cepheid Inc
Presence of unhygienic conditions around and inside hospitals and improper sterilization techniques applied in hospitals are increasing the prevalence of hospital acquired infections
Emerging economies such as India, China, Brazil, Mexico and South Africa have a large number of under-served patients. These geographies represent a huge opportunity for medical device manufacturers. Economic development in these emerging economies along with rising disposable income of patients would help the market ensuring future sustainability.
Growing healthcare infrastructure and medical expenditure by respective governments would enable installation and usage of sophisticated medical devices such as endoscopes in medical institutions like hospitals. This would increase the demand for endoscope reprocessing devices, as these are capable of disinfecting medical devices efficiently. Likewise, rise in healthcare expenditure would encourage endoscope reprocessing devices manufacturers to enter the market.
Greater focus on development of reprocessors exhibiting innovative product design to avoid cross contamination and enhance patient safety coupled with advancements in the medical device industry is expected to create a favorable platform for innovative reprocessing technologies in high-income economies such as the U.K. and U.S. Companies are expected to benefit from increasing incorporation of innovative technologies in AERs. Such systems are expected to revolutionize the cleaning process in the most effective manner in the near future.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Hospitals are gradually shifting from heat sterilization to low temperature sterilization owing to the various drawbacks related to steam heat sterilizers
The disinfection equipment segment is expected to be the most lucrative among all product types with an attractiveness index of 2.14, while the heat sterilization equipment segment is anticipated to be the second attractive segment in the hospital acquired infections control market, with an attractiveness index of 1.78.
Disinfection equipment is the largest product type in the global hospital acquired infections control market, which was estimated to represent US$ 2,585.1 Mn, or 49.6% share of the total market in 2017 and is projected to reach a market valuation of US$ 3,852.5 Mn by 2025 end, expanding at a CAGR of 5.1% over the forecast period 2017–2025.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Guidelines and recommendations of the European Respiratory Society
- Use of distal versus proximal quantitative sampling in intubated patients suspected to have ventilator associated pneumonia
- Shortened duration of antibiotic therapy from 14 days to 7 to 10 days in patients with hospital acquired pneumonia and ventilator associated pneumonia without altering clinical cure rate or increasing infection relapse rate
- Suspicion of nosocomial pneumonia, with early onset of infection with none of the usual risk factors for multidrug-resistant (MDR) pathogens versus late onset of infections with classic MDR risk factors
- Use of serum PCT levels to reduce the duration of antibiotics in patients with HAP with severe sepsis or VAP
- Choosing between a single antibiotic or a combination regimen when using broad-spectrum empiric therapy for hospital acquired pneumonia and ventilator associated pneumonia
Explore Persistence Market Research’s expertise in promulgation of the business !
By Product Type
By End User